论文部分内容阅读
目的:在研究经淋巴管内灌注抗癌药物和细胞因子等生物制剂治疗恶性肿瘤的效果。材料与方法:23例晚期转移性癌肿和2例原发性恶性淋巴瘤,对常规化疗或经动脉内化疗无效,而采用淋巴管内灌注治疗。结果:淋巴管造影注药.1月后复查淋巴结摄片和 CT 扫描进行对比,发现23例经免疫化疗的肿大淋巴结均有缩小。结论:经淋巴管灌注疗法对淋巴道路转移痛和恶性淋巴瘤是安全、有效的方法,并无严重并发症。
OBJECTIVE: To study the effect of biological agents such as anticancer drugs and cytokines in the lymphatic vessels for the treatment of malignant tumors. Materials and Methods: Twenty-three cases of advanced metastatic cancer and two cases of primary malignant lymphoma were ineffective for conventional chemotherapy or intra-arterial chemotherapy. Intralymphatic infusion therapy was used. RESULTS: Lymphatic angiography was performed. After 1 month of reconstructing lymph node radiography and CT scan, it was found that 23 cases of enlarged lymph nodes in immunochemotherapy were all reduced. Conclusion: Lymphatic perfusion therapy is a safe and effective method for lymph node metastasis pain and malignant lymphoma, and there is no serious complications.